Skip to main content
Top
Published in: BMC Cancer 1/2019

Open Access 01-12-2019 | Research article

Tumor classification and biomarker discovery based on the 5’isomiR expression level

Authors: Shengqin Wang, Zhihong Zheng, Peichao Chen, Mingjiang Wu

Published in: BMC Cancer | Issue 1/2019

Login to get access

Abstract

Background

The miRNA isoforms (isomiRs) have been suggested to regulate the same pathways as the canonical miRNA and play an important biological role in miRNA-mediated gene regulation. Recently, a study has demonstrated that the presence or absence of all isomiRs could efficiently discriminate amongst 32 TCGA cancer types. Besides, an effective reduction of distinguishing isomiR features for multiclass tumor discrimination must have a major impact on our understanding of the disease and treatment of cancer.

Methods

In this study, we have constructed a combination of the genetic algorithms (GA) with Random Forest (RF) algorithms to detect reliable sets of cancer-associated 5’isomiRs from TCGA isomiR expression data for multiclass tumor classification.

Results

We obtained 100 sets of the optimal predictive features, each of which comprised of 50–5’isomiRs that could effectively classify with an average sensitivity of 92% samples from 32 different tumor types. We calculated the frequency with which a 5’isomiR found in these sets as measuring its importance for tumor classification. Many highly frequent 5’isomiRs with different 5′ loci from canonical miRNAs were detected in these sets, supporting that the isomiRs play a significant role in the multiclass tumor classification. The further functional enrichment analysis showed that the target genes of the 10 most frequently appearing 5’isomiRs were involved in the activity of transcription activator and protein kinase and cell-cell adhesion.

Conclusions

The findings of the present study indicated that the 5’isomiRs might be employed for multiclass tumor classification and the suggested that GA/RF model could perform effective tumor classification by a series of largely independent optimal predictor 5′ isomiR sets.
Literature
1.
go back to reference Herceg Z, Hainaut P. Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis. Mol Oncol. 2007;1:26–41.CrossRef Herceg Z, Hainaut P. Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis. Mol Oncol. 2007;1:26–41.CrossRef
2.
go back to reference Cancer Genome Atlas Research Network, Weinstein JN, Collisson EA, Mills GB, KRM S, Ozenberger BA, et al. The Cancer genome atlas Pan-Cancer analysis project. Nat genet. Nat Publ Group. 2013;45:1113–20. Cancer Genome Atlas Research Network, Weinstein JN, Collisson EA, Mills GB, KRM S, Ozenberger BA, et al. The Cancer genome atlas Pan-Cancer analysis project. Nat genet. Nat Publ Group. 2013;45:1113–20.
3.
go back to reference Li Y, Kang K, Krahn JM, Croutwater N, Lee K, Umbach DM, et al. A comprehensive genomic pan-cancer classification using the Cancer genome atlas gene expression data. BMC genomics. BioMed Central. 2017;18:508. Li Y, Kang K, Krahn JM, Croutwater N, Lee K, Umbach DM, et al. A comprehensive genomic pan-cancer classification using the Cancer genome atlas gene expression data. BMC genomics. BioMed Central. 2017;18:508.
4.
go back to reference Liu JJ, Cutler G, Li W, Pan Z, Peng S, Hoey T, et al. Multiclass cancer classification and biomarker discovery using GA-based algorithms. Bioinformatics. 2005;21:2691–7.CrossRef Liu JJ, Cutler G, Li W, Pan Z, Peng S, Hoey T, et al. Multiclass cancer classification and biomarker discovery using GA-based algorithms. Bioinformatics. 2005;21:2691–7.CrossRef
5.
go back to reference Reis-Filho JS, Pusztai L. Gene expression profiling in breast cancer: classification, prognostication, and prediction. Lancet. 2011;378:1812–23.CrossRef Reis-Filho JS, Pusztai L. Gene expression profiling in breast cancer: classification, prognostication, and prediction. Lancet. 2011;378:1812–23.CrossRef
6.
go back to reference Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer; Nature Publishing Group2006;6:857–866. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer; Nature Publishing Group2006;6:857–866.
7.
go back to reference Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annu Rev Pathol. 2014;9:287–314.CrossRef Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annu Rev Pathol. 2014;9:287–314.CrossRef
8.
go back to reference Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature; Nature Publishing Group2005;435:834–838. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature; Nature Publishing Group2005;435:834–838.
9.
go back to reference Pimentel F, Bonilla P, Ravishankar YG, Contag A, Gopal N, LaCour S, et al. Technology in MicroRNA profiling: circulating MicroRNAs as noninvasive Cancer biomarkers in breast Cancer. J Lab Autom. 2015;20:574–88.CrossRef Pimentel F, Bonilla P, Ravishankar YG, Contag A, Gopal N, LaCour S, et al. Technology in MicroRNA profiling: circulating MicroRNAs as noninvasive Cancer biomarkers in breast Cancer. J Lab Autom. 2015;20:574–88.CrossRef
10.
go back to reference Etheridge A, Lee I, Hood L, Galas D, Wang K. Extracellular microRNA: a new source of biomarkers. Mutat Res. 2011;717:85–90.CrossRef Etheridge A, Lee I, Hood L, Galas D, Wang K. Extracellular microRNA: a new source of biomarkers. Mutat Res. 2011;717:85–90.CrossRef
11.
go back to reference Yan W, Xu L, Sun Z, Lin Y, Zhang W, Chen J, et al. MicroRNA biomarker identification for pediatric acute myeloid leukemia based on a novel bioinformatics model. Oncotarget. Impact Journals; 2015;6:26424–26436. Yan W, Xu L, Sun Z, Lin Y, Zhang W, Chen J, et al. MicroRNA biomarker identification for pediatric acute myeloid leukemia based on a novel bioinformatics model. Oncotarget. Impact Journals; 2015;6:26424–26436.
12.
go back to reference Neilsen CT, Goodall GJ, Bracken CP. IsomiRs--the overlooked repertoire in the dynamic microRNAome. Trends Genet. 2012;28:544–9.CrossRef Neilsen CT, Goodall GJ, Bracken CP. IsomiRs--the overlooked repertoire in the dynamic microRNAome. Trends Genet. 2012;28:544–9.CrossRef
13.
go back to reference McCall MN, Kim M-S, Adil M, Patil AH, Lu Y, Mitchell CJ, et al. Toward the human cellular microRNAome. Genome Res. 2017;27:1769–81.CrossRef McCall MN, Kim M-S, Adil M, Patil AH, Lu Y, Mitchell CJ, et al. Toward the human cellular microRNAome. Genome Res. 2017;27:1769–81.CrossRef
14.
go back to reference Mercey O, Popa A, Cavard A, Paquet A, Chevalier B, Pons N, et al. Characterizing isomiR variants within the microRNA-34/449 family. FEBS Lett. 2017;591:693–705.CrossRef Mercey O, Popa A, Cavard A, Paquet A, Chevalier B, Pons N, et al. Characterizing isomiR variants within the microRNA-34/449 family. FEBS Lett. 2017;591:693–705.CrossRef
15.
go back to reference Ameres SL, Zamore PD. Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol. 2013;14:475–88.CrossRef Ameres SL, Zamore PD. Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol. 2013;14:475–88.CrossRef
16.
go back to reference Hinton A, Hunter SE, Afrikanova I, Jones GA, Lopez AD, Fogel GB, et al. sRNA-seq analysis of human embryonic stem cells and definitive endoderm reveal differentially expressed microRNAs and novel isomiRs with distinct targets. Stem Cells. 2014. Hinton A, Hunter SE, Afrikanova I, Jones GA, Lopez AD, Fogel GB, et al. sRNA-seq analysis of human embryonic stem cells and definitive endoderm reveal differentially expressed microRNAs and novel isomiRs with distinct targets. Stem Cells. 2014.
17.
go back to reference Telonis AG, Loher P, Jing Y, Londin E, Rigoutsos I. Beyond the one-locus-one-miRNA paradigm: microRNA isoforms enable deeper insights into breast cancer heterogeneity. Nucleic Acids Res. 2015;43:9158–75.CrossRef Telonis AG, Loher P, Jing Y, Londin E, Rigoutsos I. Beyond the one-locus-one-miRNA paradigm: microRNA isoforms enable deeper insights into breast cancer heterogeneity. Nucleic Acids Res. 2015;43:9158–75.CrossRef
18.
go back to reference Wang S, Tu J, Wang L, Lu Z. Entropy-Based model for MiRNA isoform analysis. PLoS One. 2015;10:e0118856.CrossRef Wang S, Tu J, Wang L, Lu Z. Entropy-Based model for MiRNA isoform analysis. PLoS One. 2015;10:e0118856.CrossRef
19.
go back to reference Telonis AG, Magee R, Loher P, Chervoneva I, Londin E, Rigoutsos I. Knowledge about the presence or absence of miRNA isoforms (isomiRs) can successfully discriminate amongst 32 TCGA cancer types. Nucleic Acids Res. 2017;45:2973–85.CrossRef Telonis AG, Magee R, Loher P, Chervoneva I, Londin E, Rigoutsos I. Knowledge about the presence or absence of miRNA isoforms (isomiRs) can successfully discriminate amongst 32 TCGA cancer types. Nucleic Acids Res. 2017;45:2973–85.CrossRef
20.
go back to reference Kang J, Rancati T, Lee S, Oh JH, Kerns SL, Scott JG, et al. Machine learning and Radiogenomics: lessons learned and future directions. Front Oncol. 2018;8:228.CrossRef Kang J, Rancati T, Lee S, Oh JH, Kerns SL, Scott JG, et al. Machine learning and Radiogenomics: lessons learned and future directions. Front Oncol. 2018;8:228.CrossRef
21.
go back to reference Rodriguez-Galiano VF, Luque-Espinar JA, Chica-Olmo M, Mendes MP. Feature selection approaches for predictive modelling of groundwater nitrate pollution: an evaluation of filters, embedded and wrapper methods. Sci Total Environ. 2018;624:661–72.CrossRef Rodriguez-Galiano VF, Luque-Espinar JA, Chica-Olmo M, Mendes MP. Feature selection approaches for predictive modelling of groundwater nitrate pollution: an evaluation of filters, embedded and wrapper methods. Sci Total Environ. 2018;624:661–72.CrossRef
22.
go back to reference Noble WS. What is a support vector machine? Nat Biotechnol. 2006;24:1565–7.CrossRef Noble WS. What is a support vector machine? Nat Biotechnol. 2006;24:1565–7.CrossRef
23.
go back to reference Kourou K, Exarchos TP, Exarchos KP, Karamouzis MV, Fotiadis DI. Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechnol J. 2015;13:8–17.CrossRef Kourou K, Exarchos TP, Exarchos KP, Karamouzis MV, Fotiadis DI. Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechnol J. 2015;13:8–17.CrossRef
24.
go back to reference Statnikov A, Wang L. Aliferis CF. a comprehensive comparison of random forests and support vector machines for microarray-based cancer classification. BMC bioinformatics. BioMed Central. 2008;9:319. Statnikov A, Wang L. Aliferis CF. a comprehensive comparison of random forests and support vector machines for microarray-based cancer classification. BMC bioinformatics. BioMed Central. 2008;9:319.
25.
go back to reference Gan B, Zheng C-H, Zhang J, Wang H-Q. Sparse representation for tumor classification based on feature extraction using latent low-rank representation. Biomed Res Int Hindawi. 2014;2014:420856–7. Gan B, Zheng C-H, Zhang J, Wang H-Q. Sparse representation for tumor classification based on feature extraction using latent low-rank representation. Biomed Res Int Hindawi. 2014;2014:420856–7.
26.
go back to reference Mukhopadhyay A, Bandyopadhyay S, Maulik U. Multi-class clustering of Cancer subtypes through SVM based Ensemble of Pareto-Optimal Solutions for gene marker identification. Navarro A, editor PLoS ONE Public Library of Science; 2010;5:e13803. Mukhopadhyay A, Bandyopadhyay S, Maulik U. Multi-class clustering of Cancer subtypes through SVM based Ensemble of Pareto-Optimal Solutions for gene marker identification. Navarro A, editor PLoS ONE Public Library of Science; 2010;5:e13803.
27.
go back to reference Genetic algorithms in search, optimization, and machine learning. Choice Reviews Online. 1989;27:27–0936–27–0936. Genetic algorithms in search, optimization, and machine learning. Choice Reviews Online. 1989;27:27–0936–27–0936.
28.
go back to reference Tan GC, Chan E, Molnar A, Sarkar R, Alexieva D, Isa IM, et al. 5′ isomiR variation is of functional and evolutionary importance. Nucleic Acids Res. 2014;42:9424–35.CrossRef Tan GC, Chan E, Molnar A, Sarkar R, Alexieva D, Isa IM, et al. 5′ isomiR variation is of functional and evolutionary importance. Nucleic Acids Res. 2014;42:9424–35.CrossRef
29.
go back to reference Wang X. Composition of seed sequence is a major determinant of microRNA targeting patterns. Bioinformatics. 2014;30:1377–83.CrossRef Wang X. Composition of seed sequence is a major determinant of microRNA targeting patterns. Bioinformatics. 2014;30:1377–83.CrossRef
30.
go back to reference Friedman RC, Farh KK-H, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19:92–105.CrossRef Friedman RC, Farh KK-H, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19:92–105.CrossRef
31.
go back to reference Wang S, Xu Y, Li M, Tu J, Lu Z. Dysregulation of miRNA isoform level at 5 “end in Alzheimer”s disease. Gene. 2016. Wang S, Xu Y, Li M, Tu J, Lu Z. Dysregulation of miRNA isoform level at 5 “end in Alzheimer”s disease. Gene. 2016.
32.
go back to reference Salem O, Erdem N, Jung J, Münstermann E, Wörner A, Wilhelm H, et al. The highly expressed 5'isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration. BMC genomics. BioMed Central. 2016;17:566. Salem O, Erdem N, Jung J, Münstermann E, Wörner A, Wilhelm H, et al. The highly expressed 5'isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration. BMC genomics. BioMed Central. 2016;17:566.
33.
go back to reference Magee RG, Telonis AG, Loher P, Londin E, Rigoutsos I. Profiles of miRNA isoforms and tRNA fragments in prostate Cancer. Sci Rep; Nature Publishing Group2018;8:5314. Magee RG, Telonis AG, Loher P, Londin E, Rigoutsos I. Profiles of miRNA isoforms and tRNA fragments in prostate Cancer. Sci Rep; Nature Publishing Group2018;8:5314.
34.
go back to reference Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature; Nature Publishing Group2012;487:330–337. Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature; Nature Publishing Group2012;487:330–337.
35.
go back to reference Ludwig N, Leidinger P, Becker K, Backes C, Fehlmann T, Pallasch C, et al. Distribution of miRNA expression across human tissues. Nucleic Acids Res. 2016;44:3865–77.CrossRef Ludwig N, Leidinger P, Becker K, Backes C, Fehlmann T, Pallasch C, et al. Distribution of miRNA expression across human tissues. Nucleic Acids Res. 2016;44:3865–77.CrossRef
36.
go back to reference Yekta S, Shih I-H, Bartel DP. MicroRNA-directed cleavage of HOXB8 mRNA. Science. 2004;304:594–6.CrossRef Yekta S, Shih I-H, Bartel DP. MicroRNA-directed cleavage of HOXB8 mRNA. Science. 2004;304:594–6.CrossRef
37.
go back to reference Gulei D, Magdo L, Jurj A, Raduly L, Cojocneanu-Petric R, Moldovan A, et al. The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression. Cell Death Dis; Nature Publishing Group2018;9:66. Gulei D, Magdo L, Jurj A, Raduly L, Cojocneanu-Petric R, Moldovan A, et al. The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression. Cell Death Dis; Nature Publishing Group2018;9:66.
38.
go back to reference De Cola A, Volpe S, Budani MC, Ferracin M, Lattanzio R, Turdo A, et al. miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance. Cell death dis. Nat Publ Group; 2015;6:e1823–e1823. De Cola A, Volpe S, Budani MC, Ferracin M, Lattanzio R, Turdo A, et al. miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance. Cell death dis. Nat Publ Group; 2015;6:e1823–e1823.
39.
go back to reference Huerta EB, Duval B, Hao J-KA, Hybrid GA. SVM approach for gene selection and classification of microarray data. Applications of evolutionary computing. Berlin, Heidelberg: Springer Berlin Heidelberg; 2006. p. 34–44. Huerta EB, Duval B, Hao J-KA, Hybrid GA. SVM approach for gene selection and classification of microarray data. Applications of evolutionary computing. Berlin, Heidelberg: Springer Berlin Heidelberg; 2006. p. 34–44.
40.
go back to reference Agarwal V, Bell GW, Nam J-W, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4:101.CrossRef Agarwal V, Bell GW, Nam J-W, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4:101.CrossRef
41.
go back to reference Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57.CrossRef Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57.CrossRef
42.
go back to reference Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:1–13.CrossRef Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:1–13.CrossRef
43.
go back to reference Gorodkin J. Comparing two K-category assignments by a K-category correlation coefficient. Comput Biol Chem. 2004;28:367–74.CrossRef Gorodkin J. Comparing two K-category assignments by a K-category correlation coefficient. Comput Biol Chem. 2004;28:367–74.CrossRef
Metadata
Title
Tumor classification and biomarker discovery based on the 5’isomiR expression level
Authors
Shengqin Wang
Zhihong Zheng
Peichao Chen
Mingjiang Wu
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2019
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-019-5340-y

Other articles of this Issue 1/2019

BMC Cancer 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine